Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente ANNALS OF ONCOLOGY

Tipo Año Título Fuente
Artículo2024Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysisANNALS OF ONCOLOGY
Artículo2023Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC lung cancer group 1613 APPLE phase II randomized clinical trialANNALS OF ONCOLOGY
Artículo2022A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trialANNALS OF ONCOLOGY
Artículo2022Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up ☆ANNALS OF ONCOLOGY
Artículo2021Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-upANNALS OF ONCOLOGY
Corrección2021Corrigendum to 'Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival': [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024]ANNALS OF ONCOLOGY
Artículo2021Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survivalANNALS OF ONCOLOGY
Artículo2021Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ANNALS OF ONCOLOGY
Resumen congreso2020Evolution of cytotoxic and regulatory T cells in blood and in tissue after neoadjuvant treatment in breast carcinomaANNALS OF ONCOLOGY
Artículo2019Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotypingANNALS OF ONCOLOGY
Artículo2019Does PICC side matter? The experience at our hospitalANNALS OF ONCOLOGY
Resumen congreso2019Evolution of myeloid-derived suppressor cells and objective response rate in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL) patients after receiving immunotherapyANNALS OF ONCOLOGY
Resumen congreso2019IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib plus nivolumab in advanced soft tissue and bone sarcomas: Results of the phase II-soft-tissue sarcoma cohortANNALS OF ONCOLOGY
Resumen congreso2019Interim results from CompLEEment-1 (A phase IIIb study of ribociclib and letrozole as first-line therapy for advanced breast cancer in an expanded population): Spanish cohort resultsANNALS OF ONCOLOGY
Resumen congreso2019Myeloid derived-suppressor cells in healthy women and in advanced breast cancer patientsANNALS OF ONCOLOGY
Resumen congreso2019Overall survival (OS) results of the phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor 2-negative (HER2-) advanced breast cancer (ABC) treated with fulvestrant (FUL) (+) ribociclib (RIB)ANNALS OF ONCOLOGY
Resumen congreso2019Results from a phase II trial of pembrolizumab (P) plus gemcitabine (Gem) in patients (pts) with HER2-negative advanced breast cancer (ABC): GEICAM/2015-04 (PANGEA-Breast) studyANNALS OF ONCOLOGY
Artículo2018Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-upANNALS OF ONCOLOGY
Artículo2018Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patientsANNALS OF ONCOLOGY
Artículo2018Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upANNALS OF ONCOLOGY
Corrección2018Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 29, pg 68, 2018)ANNALS OF ONCOLOGY
Artículo2018nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trialANNALS OF ONCOLOGY
Resumen congreso2018Phase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962)ANNALS OF ONCOLOGY
Resumen congreso2018Run-in-phase results from a multicenter phase II trial to evaluate pembrolizumab (P) and gemcitabine (Gem) in patients (pts) with HER2-negative advanced breast cancer (ABC): GEICAM/2015-04 PANGEA-BreastANNALS OF ONCOLOGY
Artículo2018Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upANNALS OF ONCOLOGY
Corrección2018Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 29, pg 51, 2018)ANNALS OF ONCOLOGY
Artículo2017Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patientsANNALS OF ONCOLOGY
Resumen congreso2017Follicular lymphoma: clinical and mollecular characteristics of histologic transformationANNALS OF ONCOLOGY
Resumen congreso2016GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastasesANNALS OF ONCOLOGY
Resumen congreso2016Impact of the addition of rituximab in overall survival in first line chemotherapy in follicular lymphoma: a population-based study from the Spanish Lymphoma Oncology Group (GOTEL)ANNALS OF ONCOLOGY
Resumen congreso2016Outpatient management of cancer-associated pulmonary embolism (PE): analysis of lung carcinoma (LC) cohort from the Epiphany studyANNALS OF ONCOLOGY
Resumen congreso2016Phase II multi-centre, non randomized, open label study of nivolumab in combination with ipilimumab as first line in adults patients with metastatic uveal melanoma. GEM 14-02ANNALS OF ONCOLOGY
Resumen congreso2016Survival in young adults diagnosed with follicular lymphoma in a national registry from the Spanish Lymphoma Oncology GroupANNALS OF ONCOLOGY
Artículo2014362P ASSESSMENT OF TREATMENT RESPONSE WITH FULVESTRANT (F) 500 MG IN STANDARD CLINICAL PRACTICE THROUGH A RETROSPECTIVE STUDY: NCT01509625ANNALS OF ONCOLOGY
Resumen congreso2014Pathological complete response and changes related to t infiltrating lymphocytes and regulatory t cells in tissue and peripheral blood after neoadjuvant chemotherapy in breast carcinomaANNALS OF ONCOLOGY
Artículo2012Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upANNALS OF ONCOLOGY
Ponencia2012BRAF-V600 AND C-KIT MUTATION ANALYSIS IN CYTOLOGYCAL SAMPLES FROM METASTATIC MELANOMAANNALS OF ONCOLOGY
Resumen congreso2012Consolidaton treatment with Y90-ibritumomab tiuxetan after r-chop induction in high-risk patients with follicular lymphoma (fl) ( gotel -fl1lc): A multicentric, prospective study ANNALS OF ONCOLOGY
Artículo2012Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upANNALS OF ONCOLOGY
Artículo2012Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upANNALS OF ONCOLOGY
Artículo2010Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upANNALS OF ONCOLOGY
Artículo2010Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM) ANNALS OF ONCOLOGY
Ponencia2008EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), CYCLIN D1 AND P16 GENE EXPRESSIONS IN LUNG SQUAMOUS CELL CARCINOMAANNALS OF ONCOLOGY
Resumen congreso2008Phase II: Sequential scheme capecitabine-oxaliplatin followed by capecitabine-irinotecan ( oxxec-02) in first line metastatic colorectal cancer (mcrc). Study oxxec-02 ANNALS OF ONCOLOGY
Ponencia2008Proteomic analysis of the hepatocellular carcinoma: Differential expression of proteins in tumoral and non tumoral tissueANNALS OF ONCOLOGY
Resumen congreso2008QUALITY OF LIFE AND CLINICAL FEATURES OF CANCER PATIENTS RECEIVING INPATIENT AND HOME-BASED PALLIATIVE CARE IN A TERTIARY TEACHING HOSPITALANNALS OF ONCOLOGY
Ponencia2008Serum apolipoprotein-A4 is a potential biomarker of hepatocellular carcinoma in cirrhotic patientsANNALS OF ONCOLOGY
Letter2008The risk of taking the part by the wholeANNALS OF ONCOLOGY
Ponencia2006Bevacizumab and weekly taxol combination in previously treated metastatic melanoma patientsANNALS OF ONCOLOGY
Artículo2004Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experienceANNALS OF ONCOLOGY
Artículo2004Joinpoint regression analysis of lung cancer mortality, Andalusia 1975-2000ANNALS OF ONCOLOGY
Artículo2003High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative GroupANNALS OF ONCOLOGY